CDH1 and neoplasm: In this study, we analyzed multiple large transcriptomics, proteomics, and immunohistochemistry datasets on clinical cancer samples and cancer cell lines to determine the levels of CDH1 mRNA and E-cad protein in different carcinomas during tumor progression.